Search
for
Sort by
Research 361–390 of 786
- Deciphering the Complex Immunopathogenesis of Alopecia Areata
- Comparison of Current International Guidelines for the Management of Alopecia Areata—Comprehensive Review
- Integrated Analysis of Methylome and Transcriptome Changes Reveals the Underlying Regulatory Signatures Driving Curly Wool Transformation in Chinese Zhongwei Goats
- Treatment of Refractory Segmental Vitiligo and Alopecia Areata in a Child with Upadacitinib and NB-UVB: A Case Report
- Biologics and Small Molecule Targeted Therapies for Pediatric Alopecia Areata, Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa in the US: A Narrative Review
- Alopecia Areata: Current and Emerging Therapies
- Towards cell-based therapy of alopecia areata: Autologous human Vδ2+ Foxp3+ γδTreg cells restore hair-follicle immune privilege and promote hair regrowth in human alopecia areata models ex vivo and in vivo
- Cutaneous lesions and clinical outcomes in five cats after frunevetmab injections
- Combined Systemic and Cutaneous Ovalbumin–Aluminum Sensitization Triggers Thermal Hyperalgesia, Spinal Gliosis, and Nociceptive Nerve Fibers Sprouting in Mice
- Dissecting Cellulitis of the Scalp: Linking Pathogenesis to Therapy
- Primary cicatricial alopecias are characterized by dysregulation of shared gene expression pathways
- Analysing the dynamics of a model for alopecia areata as an autoimmune disorder of hair follicle cycling
- Lichen Planopilaris Responsive to a Novel Phytoactive Botanical Treatment: A Case Series
- Alopecia Areata
- 50285 Oxytocin receptor is present in keratinocytes near touch and pain sensory neurons
- Autoinmune Alopecia/Alopecia Areata
- Hair Loss in an 11-year-old
- Alopecia Areata: Clinical Treatment
- European expert consensus statement on the systemic treatment of alopecia areata
- SYSTEMATIC REVIEW OF PHARMACOTHERAPY STRATEGIES IN THE MANAGEMENT OF HIDRADENITIS SUPPURATIVA
- P718 Observational real-world evidence on the efficacy and safety of Janus Kinase inhibitors (JAKi) in the treatment of moderate to severe Active Ulcerative Colitis (UC)
- Sublingual tofacitinib for alopecia areata: a roll‐over pilot clinical trial and analysis of pharmacokinetics
- Treatment of alopecia areata with JAK inhibitors: a review of the literature
- Tofacitinib for the treatment of alopecia areata and variants in adolescents
- Turning JAK STATic, a peek into the future of dermatology therapeutics
- Good efficacy achieved by telitacicept in treatment of systemic lupus erythematosus with alopecia areata
- ORAL TOFACITINIB IN MODERATE AND SEVERE ALOPECIA AREATA: CASE SERIES OF 14 PATIENTS
- Experience with oral tofacitinib in severe alopecia areata with different clinical responses
- Emerging treatments in alopecia
- Extensive alopecia areata is reversed by IL-12/IL-23p40 cytokine antagonism